BOTOX ALLERGAN
BOTOX by Allergan (AbbVie) is the global gold standard in botulinum toxin, with FDA approval since 1989 and the most extensive clinical evidence base of any brand. Available in 100+ countries, it uses onabotulinumtoxinA in a 900kDa complex. Onset 3–5 days, duration 4–6 months, widely available at top Thai aesthetic clinics.
30 分鐘
免費諮詢 · 專屬顧問 · 無額外費用
療程效果
- 全球黃金標準，30 年以上臨床使用歷史，安全性最充分驗證
- 1989 年獲美國 FDA 核准，全球 100 多國上市
- 醫師最熟悉的品牌，劑量控制與療效預測性最高
- 適用範圍最廣，涵蓋除皺、瘦臉、美人肩、小腿、多汗症等
- 全球使用人次最多，臨床文獻資料最豐富
- 泰國頂級醫美診所普遍提供，品質信賴度高
適合對象
- 追求最高安全保障、偏好全球公認黃金標準品牌者
- 初次嘗試肉毒注射、希望選用最有保障品牌的新手
- 眉間紋（11 字紋）、抬頭紋、魚尾紋等臉部動態紋困擾者
- 咀嚼肌肥大（國字臉）需瘦臉塑型者
- 斜方肌發達（厚肩膀）或小腿肌肉肥大需雕塑者
- 腋下或手腳多汗症困擾者
注意事項
Avoid lying down and vigorous activity for 4 hours post-injection. Strictly contraindicated in pregnancy, breastfeeding, myasthenia gravis, and Lambert-Eaton syndrome. Stop blood thinners 2 weeks prior. Ensure treatment is performed at a licensed medical facility using authentic Allergan product.
常見問題
BOTOX ALLERGAN 適合哪些人？+
BOTOX ALLERGAN 療程需要多久？+
BOTOX ALLERGAN 有哪些注意事項？+
如何透過 BeaVoy 預約 BOTOX ALLERGAN？+
你可能也感興趣
GOURI
GOURI is the world's first fully liquid PCL (polycaprolactone) injectable collagen stimulator, developed by Korean company Dexlevo using patented CESABP technology. Injected at just 10 facial points in under 20 minutes, it spreads evenly to stimulate fibroblasts across the full face and neck, producing gradual collagen regeneration that lasts 6–12 months with minimal downtime.
了解更多XEOMIN
XEOMIN (incobotulinumtoxinA) by Germany's Merz is the world's only "naked" botulinum toxin, stripped of all complexing proteins via proprietary XTRACT dual-purification technology. This minimizes antibody formation risk, making it the preferred choice for patients with prior botulinum toxin resistance. Onset is 2–4 days, with effects lasting 4–6 months.
了解更多NEURAMIS
NEURAMIS is a Korean HA filler by Medytox using proprietary SHAPE cross-linking technology with ultra-low residual BDDE levels, certified by both the US FDA and European EDQM. Results last 8–18 months with a clinical two-year response rate of 84%.
了解更多